ClinicalTrials.gg
Status unknownNCT00826254Updated Jul 6, 2011

Nutritional Problems After Lung and Heart Transplantation

An interventional study of Vitamin K and Vitamin K in Bone Density and Overweight, sponsored by Oslo University Hospital. Status unknown at 1 site in Norway. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2011-07-06.

Sponsored by Oslo University Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Jan 2009), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Part 1) Bone health after transplantation - possible influence of vitamin K

Part 2) Fat metabolism and endocrine parameters - possible predictors for developement of overweight after transplantation

02

Conditions studied

  • Bone Density
  • Overweight

Browse trials for

Keywords

  • vitamin K
  • Bone Mineral Density
  • undercarboxylated osteocalcin
03

In context

Overweight

3,767 studies on the registry are indexed under Overweight; 863 are open to participants now.

This study's enrollment of 94 is above the median of 73 across 3,263 interventional studies indexed under Overweight.

Browse Overweight studies →

Lead sponsor

Oslo University Hospital is the lead sponsor of 830 studies on the registry; 146 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • accepted for transplantation

Exclusion criteria

Exclusion Criteria:

  • not accepted for transplantation
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
94 participants (actual)

Interventions

  • 180 micrograms vitamin K daily

    Also known as: Natto

  • 2 capsules daily 180 micrograms vitamin K daily or placebo 1 year

    Also known as: Natto

06

What researchers measure

Primary outcomes

  1. plasma vitamin K

    Time frame: 1 year

Secondary outcomes

  1. Bone mineral density

    Time frame: 1 year

07

Study locations

1 site
  • Rikshospitalet HF
    Oslo, Oslo, Norway
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 6, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00826254
Collaborators
Norwegian Foundation for Health and Rehabilitation
First posted
Jan 22, 2009
Start date
Aug 2003
Primary completion
Apr 2007
Completion
Dec 2011 (estimated)
Last update
Jul 6, 2011

Study contacts

Liv Forli, Dr
principal investigator · Oslo University Hospital
Liv Forli, Dr
study director · Oslo University Hospital
Oystein Bjortuft, MD
study chair · Oslo University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Vitamin K 1

Start the discussion